<DOC>
	<DOCNO>NCT00925847</DOCNO>
	<brief_summary>The purpose study determine whether lithium safe effective treatment ALS</brief_summary>
	<brief_title>Effect Lithium Carbonate Patients With Amyotrophic Lateral Sclerosis</brief_title>
	<detailed_description>Daily dose lithium , find delay progression amyotrophic lateral sclerosis ( ALS ) 15-month study 44 patient ALS . At end trial , 30 percent patient take riluzole die , receive riluzole plus lithium survive . lithium group slow progression measure test breathing ( FVC ) strength . This study determine whether lithium combination riluzole delay progression patient amyotrophic lateral sclerosis disease comparison historical cohort ALS patient treat riluzole alone .</detailed_description>
	<mesh_term>Sclerosis</mesh_term>
	<mesh_term>Motor Neuron Disease</mesh_term>
	<mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
	<mesh_term>Lithium Carbonate</mesh_term>
	<criteria>Diagnosis clinically possible , clinically probable laboratorysupported , clinically probable clinically definite ALS ( accord WNF EL Escorial diagnostic criterion , revise accord AIRLIE House Conference 1998 ) Concomitant standard Riluzole therapy ( 50mg twice daily ) patient include ALS reference center woman childbearing age nonlactating surgically sterile use highly effective method birth control negative pregnancy test capable thoroughly understand information give give full inform consent accord GCP Patients gastrostomy evidence major psychiatric disorder clinically evident dementia preclude evaluation symptom medical condition know contreindicate lithium treatment ( dysthyroid , cardiopathy , renal insufficiency ) presence concomitant lifethreatening disease impairment likely interfere functional assessment know hypersensitivity component study drug</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
	<keyword>Amyotrophic lateral sclerosis</keyword>
	<keyword>Lithium</keyword>
	<keyword>Survival</keyword>
</DOC>